Skip to main content
OpenTrials

Clinical trial condition

Liver Cirrhosis, Biliary

Explore clinical trials studying Liver Cirrhosis, Biliary. Study availability and eligibility vary by location and protocol.

150 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Liver Cirrhosis, Biliary trial results

Recruiting

A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

NCT06447168

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Southern California Research Center Coronado, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
  • South Denver Gastroenterology,P.C. Englewood, Colorado, United States
View all 74 locations
View Trial Details
Recruiting

A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

NCT06016842

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • Arizona Liver Health Tucson, Arizona, United States
  • Arkansas Diagnostic Center, PA Little Rock, Arkansas, United States
  • Southern California Research Center Coronado, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 186 locations
View Trial Details
Recruiting

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

NCT06051617

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • St. Joseph's Hospital and Medical Center - 350 W. Thomas Phoenix, Arizona, United States
  • OM Research LLC Lancaster, California, United States
  • SCPMG/Kaiser Permanente Los Angeles Medical Center Los Angeles, California, United States
View all 211 locations
View Trial Details
Recruiting

A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA

NCT07282353

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
Locations
  • The First Affiliated Hospital of USTC Anhui Provincial Hospital Hefei, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • The Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
View all 42 locations
View Trial Details
Recruiting

Austrian PBC Registry

NCT07598669

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +11 more
Locations
  • Klinikum Klagenfurt am Wörthersee Klagenfurt, Carinthia, Austria
  • Universitätsklinikum St. Pölten Sankt Pölten, Lower Austria, Austria
  • Universitätsklinikum Salzburg Salzburg, State of Salzburg, Austria
  • Klinik Landstraße Vienna, State of Vienna, Austria
View Trial Details

Related conditions